JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hernández-López, C.
Right arrow Articles by de la Torre, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hernández-López, C.
Right arrow Articles by de la Torre, R.

Vol. 300, Issue 1, 236-244, January 2002

3,4-Methylenedioxymethamphetamine (Ecstasy) and Alcohol Interactions in Humans: Psychomotor Performance, Subjective Effects, and Pharmacokinetics

Cándido Hernández-López, Magí Farré , Pere N. Roset , Esther Menoyo, Nieves Pizarro, Jordi Ortuño, Marta Torrens, Jordi Camí and Rafael de la Torre

Unit of Pharmacology, Institut Municipal d'Investigació Mèdica (C.H.-L., M.F., P.N.R., E.M., N.P., J.O., J.C., R.T.); Universitat Autònoma de Barcelona (M.F., P.N.R., R.T.); Unit of Psychiatry, Hospital del Mar (M.T.), and Universitat Pompeu Fabra, Barcelona, Spain (J.C.)

3,4-Methylenedioxymethamphetamine (MDMA) is frequently consumed in association with alcohol. The effect of this combination in humans has not been previously investigated. Nine male healthy volunteers received single oral doses of 100 mg of MDMA plus 0.8 g/kg ethanol, 100 mg of MDMA, 0.8 g/kg of ethanol, and placebo in a double blind, double dummy, randomized crossover trial. Measurements included psychomotor performance, subjective effects, and pharmacokinetics. Plasma concentrations of MDMA showed a 13% increase after the use of alcohol, whereas plasma concentrations of alcohol showed a 9 to 15% decrease after MDMA administration. The MDMA-alcohol combination induced longer lasting euphoria and well being than MDMA or alcohol alone. MDMA reversed the subjective sedation induced by alcohol but did not reduce drunkenness feelings. MDMA did not reverse the actions of alcohol on psychomotor abilities. Combined use of MDMA and alcohol causes dissociation between subjective and objective sedation. Subjects may feel euphoric and less sedated and might have the feeling of doing better, but actual performance ability continues to be impaired by the effect of alcohol. Confirmation of these findings in further studies will be highly relevant in terms of road safety.


0022-3565/02/3001-0236$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. Farre, S. Abanades, P. N. Roset, A. M. Peiro, M. Torrens, B. O'Mathuna, M. Segura, and R. de la Torre
Pharmacological Interaction between 3,4-Methylenedioxymethamphetamine (Ecstasy) and Paroxetine: Pharmacological Effects and Pharmacokinetics
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 954 - 962.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
A. C. Parrott
MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress
J Psychopharmacol, March 1, 2006; 20(2): 147 - 163.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
G. J. H. Dumont and R. J. Verkes
A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers
J Psychopharmacol, March 1, 2006; 20(2): 176 - 187.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Pacifici, S. Pichini, P. Zuccaro, M. Farre, M. Segura, J. Ortuno, S. Di Carlo, A. Bacosi, P. N. Roset, J. Segura, et al.
Paroxetine Inhibits Acute Effects of 3,4-Methylenedioxymethamphetamine on the Immune System in Humans
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 285 - 292.
[Abstract] [Full Text]


Home page
PsychosomaticsHome page
J. R. Oesterheld, S. C. Armstrong, and K. L. Cozza
Ecstasy: Pharmacodynamic and Pharmacokinetic Interactions
Psychosomatics, February 1, 2004; 45(1): 84 - 87.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
J. Maskalyk
Drinking and driving
Can. Med. Assoc. J., February 4, 2003; 168(3): 313 - 313.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.